Telix Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 4 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2023 | Dec2024 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Efficiency | ||||
| Inventory AverageInventory Avg. | 18.11M | 31.01M | 38.05M | |
| Assets AverageAssets Avg. | 627.98M | 1,077.83M | 1,262.92M | |
| Invested CapitalInvested Cap. | 102.91M | 744.87M | 820.40M | 1,004.06M |
| Leverage & Solvency | ||||
| Debt Ratio | 0.02 | 0.38 | 0.35 | 0.38 |